Furen Group Pharmaceutical Co.,Ltd. Posted 552.5 Million Yuan Net Loss in First Three Quarters of 2021

Furen Group Pharmaceutical Co.,Ltd. (辅仁药业集团制药股份有限公司) (600781.SH) reported a net loss of 552.5 million yuan in the first three quarters of 2021, reversing a net profit of 88.3 million yuan for the same period in the previous year.

Meanwhile, the company posted 1.3 billion yuan in revenue, down 37% year-on-year.

At the end of the reporting period, it had 10.6 billion yuan in total assets and 7.1 billion yuan in total liabilities, with a liability-to-asset ratio of 67.2%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.